• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

David Kendall - Articles and news items

Boehringer Ingelheim logo

Lilly and Boehringer Ingelheim present health outcomes data for investigational novel basal insulin analogue

Industry news, News / 2 October 2012 / Boehringer Ingelheim

Patient-reported health outcomes data from a Phase II study…

Boehringer Ingelheim logo


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +